https://www.prnewswire.com/news-releases/arena-pharmaceuticals-reports-positive-phase-2a-results-for-olorinab-in-patients-with-abdominal-pain-associated-with-crohns-disease-300717790.html
Arena Pharmaceuticals Reports Positive Phase 2a Results for Olorinab in Patients with Abdominal...
/PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline results from its Phase 2a trial of olorinab, an investigational,...